Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
Plus components not separately reported this period.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
FAQ
- What is Bicara Therapeutics's EBIT?
- Bicara Therapeutics (BCAX) reported EBIT of -$60.24M in Q1 2026.
- How has Bicara Therapeutics's EBIT changed year-over-year?
- Bicara Therapeutics's EBIT decreased by 44.2% year-over-year, from -$41.79M to -$60.24M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Bicara Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude